Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Place your pharma strategy bets: focused or cheap?

This article was originally published in Scrip

Executive Summary

For a pharma company, tax inversion has been such a painless way to make money go further that the theme has somewhat obscured the other motives for industry deal-making. However, with the US Treasury's abrupt tightening of the reins on 22 September (, 23 September 2014), it may be time to take a step back and consider what those other drivers might be.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts